EditorialCovid-19 Commentaries
Open Access
Nuclear Medicine Operations in the Times of COVID-19: Strategies, Precautions, and Experiences
Johannes Czernin, Stefano Fanti, Philipp T. Meyer, Martin Allen-Auerbach, Marcus Hacker, Mike Sathekge, Rodney Hicks, Andrew M. Scott, Jun Hatazawa, Mijin Yun, Heiko Schöder, Peter Bartenstein and Ken Herrmann
Journal of Nuclear Medicine May 2020, 61 (5) 626-629; DOI: https://doi.org/10.2967/jnumed.120.245738
Johannes Czernin
1Ahmanson Translation Imaging Division, David Geffen School of Medicine at UCLA, Los Angeles, California
Stefano Fanti
2Department of Oncology, Division of Nuclear Medicine, University of Bologna, Bologna, Italy
Philipp T. Meyer
3Department of Nuclear Medicine, Medical Centre – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
Martin Allen-Auerbach
1Ahmanson Translation Imaging Division, David Geffen School of Medicine at UCLA, Los Angeles, California
Marcus Hacker
4Department of Nuclear Medicine; Medical University of Vienna, Vienna General Hospital, Vienna, Austria
Mike Sathekge
5Nuclear Medicine Department, University of Pretoria and Steve Biko Academic Hospital, Pretoria, South Africa
Rodney Hicks
6Molecular Imaging and Therapeutic Nuclear Medicine, the Peter MacCallum Cancer Centre, Melbourne, Australia
Andrew M. Scott
7Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia
Jun Hatazawa
8Department of Quantum Cancer Therapy, Research Centre for Nuclear Physics, Osaka University, Osaka, Japan
Mijin Yun
9Department of Nuclear Medicine; Yonsei University Hospital System, Seoul, South Korea
Heiko Schöder
10Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
Peter Bartenstein
11Department of Nuclear Medicine, University Hospital of Munich, LMU, Munich, Germany; and
Ken Herrmann
12Department of Nuclear Medicine, Universitätsklinikum Essen, Essen, Germany
In this issue
Journal of Nuclear Medicine
Vol. 61, Issue 5
May 1, 2020
Nuclear Medicine Operations in the Times of COVID-19: Strategies, Precautions, and Experiences
Johannes Czernin, Stefano Fanti, Philipp T. Meyer, Martin Allen-Auerbach, Marcus Hacker, Mike Sathekge, Rodney Hicks, Andrew M. Scott, Jun Hatazawa, Mijin Yun, Heiko Schöder, Peter Bartenstein, Ken Herrmann
Journal of Nuclear Medicine May 2020, 61 (5) 626-629; DOI: 10.2967/jnumed.120.245738
Nuclear Medicine Operations in the Times of COVID-19: Strategies, Precautions, and Experiences
Johannes Czernin, Stefano Fanti, Philipp T. Meyer, Martin Allen-Auerbach, Marcus Hacker, Mike Sathekge, Rodney Hicks, Andrew M. Scott, Jun Hatazawa, Mijin Yun, Heiko Schöder, Peter Bartenstein, Ken Herrmann
Journal of Nuclear Medicine May 2020, 61 (5) 626-629; DOI: 10.2967/jnumed.120.245738
Jump to section
- Article
- STEFANO FANTI, MD: DEPARTMENT OF ONCOLOGY, DIVISION OF NUCLEAR MEDICINE, UNIVERSITY OF BOLOGNA, BOLOGNA, ITALY
- KEN HERRMANN, MD, MBA: CHAIR, DEPARTMENT OF NUCLEAR MEDICINE, UNIVERSITÄTSKLINIKUM ESSEN, ESSEN, GERMANY
- PHILIPP T. MEYER, MD, PHD: CHAIR, DEPARTMENT OF NUCLEAR MEDICINE, MEDICAL CENTRE – UNIVERSITY OF FREIBURG, FREIBURG, GERMANY
- MARTIN ALLEN-AUERBACH, MD: DIRECTOR OF NUCLEAR MEDICINE, DAVID GEFFEN SCHOOL OF MEDICINE AT UCLA, LOS ANGELES, CALIFORNIA
- MARCUS HACKER, MD: DIRECTOR OF NUCLEAR MEDICINE, MEDICAL UNIVERSITY OF VIENNA, VIENNA GENERAL HOSPITAL, VIENNA, AUSTRIA
- MIKE SATHEKGE, MD, PHD: HEAD OF NUCLEAR MEDICINE DEPARTMENT, UNIVERSITY OF PRETORIA AND STEVE BIKO ACADEMIC HOSPITAL, PRETORIA, SOUTH AFRICA
- RODNEY HICKS, MD: DIRECTOR, MOLECULAR IMAGING AND THERAPEUTIC NUCLEAR MEDICINE, THE PETER MACCALLUM CANCER CENTRE, MELBOURNE, AUSTRALIA
- ANDREW SCOTT, MD: DIRECTOR, DEPARTMENT OF MOLECULAR IMAGING AND THERAPY, AUSTIN HEALTH, MELBOURNE, AUSTRALIA
- JUN HATAZAWA, MD, PHD: DEPARTMENT OF QUANTUM CANCER THERAPY, RESEARCH CENTRE FOR NUCLEAR PHYSICS, OSAKA UNIVERSITY, OSAKA, JAPAN
- MIJIN YUN, MD: DEPARTMENT OF NUCLEAR MEDICINE, YONSEI UNIVERSITY HOSPITAL SYSTEM, SEOUL, SOUTH KOREA
- HEIKO SCHÖDER, MD, MBA: CHIEF, MOLECULAR IMAGING AND THERAPY SERVICE, DEPARTMENT OF RADIOLOGY, MEMORIAL SLOAN KETTERING CANCER CENTER (MSKCC), NEW YORK, NEW YORK
- SUMMARY
- TAKE HOME MESSAGES
- DISCLOSURE
- Footnotes
- Figures & Data
- Info & Metrics
Related Articles
Cited By...
- The Impact of the Coronavirus Disease 2019 Pandemic on the Clinical Environment
- Global Issues of Radiopharmaceutical Access and Availability: A Nuclear Medicine Global Initiative Project
- Post-COVID-19 New Normal for Nuclear Medicine Practice: An Australasian Perspective
- Global Impact of COVID-19 on Nuclear Medicine Departments: An International Survey in April 2020
- The Impact of COVID-19 on the Health-Care Workforce: from Heroes to Zeroes?
- Two Leaders
- Dr. Li Wenliang and the Time of COVID-19